American International Group, Inc. Cassava Sciences Inc Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.44 - $26.41 $1,106 - $1,584	60 Added 0.3%	19,829 $402,000
Q4 2023 Feb 13, 2024	SELL	$12.64 - $30.11 $998 - $2,378	-79 Reduced 0.4%	19,769 $445,000
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $11,731 - $17,850	705 Added 3.68%	19,848 $330,000
Q2 2023 Aug 04, 2023	BUY	$21.59 - $27.88 $15,868 - $20,491	735 Added 3.99%	19,143 $469,000
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $8,586 - $13,337	366 Added 2.03%	18,408 $444,000
Q4 2022 Feb 10, 2023	SELL	$27.82 - $44.16 $1,836 - $2,914	-66 Reduced 0.36%	18,042 $532,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $4,180 - $13,071	256 Added 1.43%	18,108 $757,000
Q2 2022 Aug 12, 2022	SELL	$17.22 - $38.47 $19,699 - $44,009	-1,144 Reduced 6.02%	17,852 $502,000
Q1 2022 May 13, 2022	SELL	$32.6 - $53.05 $43,586 - $70,927	-1,337 Reduced 6.58%	18,996 $706,000
Q4 2021 Feb 11, 2022	SELL	$36.77 - $90.91 $22,356 - $55,273	-608 Reduced 2.9%	20,333 $889,000
Q3 2021 Nov 12, 2021	SELL	$41.79 - $135.3 $20,811 - $67,379	-498 Reduced 2.32%	20,941 $1.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.15 - $89.72 $76,677 - $213,982	2,385 Added 12.52%	21,439 $1.83 Million
Q1 2021 May 07, 2021	BUY	$7.09 - $87.95 $354 - $4,397	50 Added 0.26%	19,054 $856,000
Q4 2020 Feb 12, 2021	BUY	$6.79 - $12.25 $34,941 - $63,038	5,146 Added 37.13%	19,004 $130,000
Q3 2020 Nov 04, 2020	SELL	$2.86 - $11.51 $900 - $3,625	-315 Reduced 2.22%	13,858 $160,000
Q2 2020 Aug 12, 2020	BUY	$2.04 - $9.64 $28,912 - $136,627	14,173 New	14,173 $44,000

184

13.3M

1.38M

2.04M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.18B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.